Compound Radar

Privia Health Group, Inc. (PRVA) Stock Analysis

Price $20.78
Market cap $2.65B
Next earnings Nov 5, 2026
Entry status Wait

Last updated Sep 8, 2026

Health Check

Last analyzed Sep 7, 2026

64
64/100 Good Quality
  • Financial Health 85
  • Profitability 45
  • Business Quality 60
  • Balance Sheet 65
  • Cash Flow 70

Why this rating?

Health 64/100 — Good Quality

Strongest Financial Health 85/100
Softest Profitability 45/100
Wait

Entry timing is weak right now. Quality may be fine; the setup is not.

Company overview

Privia Health Group, Inc. (PRVA) is a Health Information Services company in the Healthcare sector. Compound Radar rates Privia Health Group, Inc. 64/100 (Good Quality) due to solid business quality, strong revenue growth, and manageable leverage.

Investment profile

  • Quality Moderate
  • Growth Strong
  • Balance Sheet Adequate
  • Valuation Fair

Financial highlights

Valuation

  • P/E 94.45
  • Forward P/E 19.54
  • EV/Revenue 0.97

Profitability

  • Revenue Growth 21.4%
  • Gross Margin 10.0%
  • Operating Margin 1.9%
  • Net Margin 1.2%
  • ROE 4.3%

Financial strength

  • Cash $412.20M
  • Debt $8.73M
  • Net Cash $403.47M
  • Free Cash Flow $163.40M
  • Current Ratio 1.62

Similar companies

Peers in Health Information Services, ranked by Financial Health.

Company Ticker
Price Current price

Latest quoted price for the name. Helps anchor the setup in today’s market level.

Health Entry

View all in Health Information Services →

FAQ

How Compound Radar scores and tracks Privia Health Group, Inc. (PRVA).

View Methodology & FAQ →